Nobuhiko Uoshima

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: July 18, 2026

Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia

Alemtuzumab-based HLA-haploidentical transplantation for relapsed/refractory aggressive NK-cell leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Journal: Annals of hematology

Published: May 10, 2026

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

Journal: Blood cancer journal

Published: February 14, 2026

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

Non-infectious fever defines a subgroup of patients with poorer survival outcomes in high-risk myelodysplastic syndrome.

Journal: British journal of haematology

Published: February 02, 2026

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma.

Journal: Cureus

Published: January 29, 2026

Lead poisoning diagnosed in a patient with anemia accompanied by abdominal pain

Lead poisoning diagnosed in a patient with anemia accompanied by abdominal pain

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 05, 2025

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: October 01, 2025

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: October 01, 2025

Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).

Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).

Journal: International journal of hematology

Published: June 15, 2025

Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum.

Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 29, 2025

Clinical issues and perspectives in diffuse large B-cell lymphoma based on 15 years of clinical studies by the Kyoto Hematology Clinical Research Group (KOTOSG)

Clinical issues and perspectives in diffuse large B-cell lymphoma based on 15 years of clinical studies by the Kyoto Hematology Clinical Research Group (KOTOSG)

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 02, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026